MCK
McKesson Corporation
Price Chart
Latest Quote
$843.27
| Previous Close | $841.31 |
| Open | $852.81 |
| Day High | $860.97 |
| Day Low | $843.25 |
| Volume | 464,301 |
Stock Information
| Quarterly Dividend / Yield | $3.28 / 0.39% |
| Shares Outstanding | 117.08M |
| Quarterly Dividend Yield | 0.39% |
| Quarterly Dividend | $3.28 |
| Total Debt | $8.79B |
| Cash Equivalents | $3.98B |
| Revenue | $403.43B |
| Net Income | $4.76B |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $98.73B |
| P/E Ratio | 21.98 |
| EPS (TTM) | $38.36 |
| Exchange | NYQ |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $841.39 | 1,118,600 |
| 2026-07-16 | $841.31 | 1,329,400 |
| 2026-07-15 | $796.35 | 664,800 |
| 2026-07-14 | $803.37 | 1,115,700 |
| 2026-07-13 | $812.28 | 618,700 |
| 2026-07-10 | $805.96 | 491,700 |
| 2026-07-09 | $792.81 | 1,005,200 |
| 2026-07-08 | $818.66 | 1,125,400 |
| 2026-07-07 | $807.33 | 1,109,900 |
| 2026-07-06 | $784.23 | 1,130,500 |
| 2026-07-02 | $786.30 | 952,600 |
| 2026-07-01 | $768.06 | 1,200,700 |
| 2026-06-30 | $755.60 | 1,688,400 |
| 2026-06-29 | $747.53 | 1,559,900 |
| 2026-06-26 | $763.51 | 1,736,100 |
| 2026-06-25 | $763.81 | 1,186,600 |
| 2026-06-24 | $766.55 | 1,279,000 |
| 2026-06-23 | $763.91 | 1,363,600 |
| 2026-06-22 | $744.85 | 1,454,600 |
| 2026-06-18 | $750.63 | 2,477,000 |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
đ° Latest News
McKesson's Q1 2027 Earnings: What to Expect
Barchart âĸ 2026-07-17T10:54:14ZHereâs Why McKesson Corporation (MCK) Slid in Q2
Insider Monkey âĸ 2026-07-16T14:36:21ZCheniere Energy (LNG) Appoints Britt Vitalone As It Reworks Key Credit Lines
Simply Wall St. âĸ 2026-07-16T10:12:57Z2 Profitable Stocks Worth Investigating and 1 We Turn Down
StockStory âĸ 2026-07-15T07:26:25ZMcKesson (MCK) Stock Dips While Market Gains: Key Facts
Zacks âĸ 2026-07-14T22:00:04ZZacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
Zacks âĸ 2026-07-14T07:31:00Z5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds
Zacks âĸ 2026-07-13T16:36:00ZMcKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough?
Simply Wall St. âĸ 2026-07-11T17:06:22ZCan McKesson (MCK) Stay Cheap After A 338% Five Year Run?
Simply Wall St. âĸ 2026-07-11T09:10:01ZMcKesson (MCK) CEO Sells Shares As Company Names A New Strategy Chief
Simply Wall St. âĸ 2026-07-11T02:10:37ZIncome Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $388,880,000,000 | $345,728,000,000 | $296,123,000,000 | $264,353,000,000 |
| Cost Of Revenue | $388,880,000,000 | $345,728,000,000 | $296,123,000,000 | $264,353,000,000 |
| Total Revenue | $403,430,000,000 | $359,051,000,000 | $308,951,000,000 | $276,711,000,000 |
| Operating Revenue | $403,430,000,000 | $359,051,000,000 | $308,951,000,000 | $276,711,000,000 |
| Expenses | ||||
| Interest Expense | $247,000,000 | $265,000,000 | $252,000,000 | $248,000,000 |
| Total Expenses | $396,976,000,000 | $354,235,000,000 | $304,780,000,000 | $272,129,000,000 |
| Other Income Expense | $-185,000,000 | $-365,000,000 | $-248,000,000 | $189,000,000 |
| Other Non Operating Income Expenses | $44,000,000 | $-38,000,000 | $34,000,000 | $279,000,000 |
| Net Non Operating Interest Income Expense | $-68,000,000 | $-92,000,000 | $-134,000,000 | $-141,000,000 |
| Interest Expense Non Operating | $247,000,000 | $265,000,000 | $252,000,000 | $248,000,000 |
| Operating Expense | $8,096,000,000 | $8,507,000,000 | $8,657,000,000 | $7,776,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $4,762,000,000 | $3,295,000,000 | $3,002,000,000 | $3,563,000,000 |
| Net Interest Income | $-68,000,000 | $-92,000,000 | $-134,000,000 | $-141,000,000 |
| Interest Income | $179,000,000 | $173,000,000 | $118,000,000 | $107,000,000 |
| Normalized Income | $4,950,238,000 | $3,556,273,000 | $3,237,186,065 | $3,635,450,000 |
| Net Income From Continuing And Discontinued Operation | $4,762,000,000 | $3,295,000,000 | $3,002,000,000 | $3,560,000,000 |
| Total Operating Income As Reported | $6,212,000,000 | $4,422,000,000 | $3,909,000,000 | $4,381,000,000 |
| Net Income Common Stockholders | $4,762,000,000 | $3,295,000,000 | $3,002,000,000 | $3,560,000,000 |
| Net Income | $4,762,000,000 | $3,295,000,000 | $3,002,000,000 | $3,560,000,000 |
| Net Income Including Noncontrolling Interests | $5,099,000,000 | $3,481,000,000 | $3,160,000,000 | $3,722,000,000 |
| Net Income Continuous Operations | $5,099,000,000 | $3,481,000,000 | $3,160,000,000 | $3,725,000,000 |
| Pretax Income | $6,201,000,000 | $4,359,000,000 | $3,789,000,000 | $4,630,000,000 |
| Special Income Charges | $-242,000,000 | $-394,000,000 | $-262,000,000 | $-201,000,000 |
| Interest Income Non Operating | $179,000,000 | $173,000,000 | $118,000,000 | $107,000,000 |
| Operating Income | $6,454,000,000 | $4,816,000,000 | $4,171,000,000 | $4,582,000,000 |
| Gross Profit | $14,550,000,000 | $13,323,000,000 | $12,828,000,000 | $12,358,000,000 |
| Net Income Discontinuous Operations | - | $0 | $0 | $-3,000,000 |
| Earnings From Equity Interest | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $38.38 | $25.72 | $22.39 | $25.03 |
| Basic EPS | $38.55 | $25.86 | $22.54 | $25.23 |
| Other | ||||
| Tax Effect Of Unusual Items | $-40,762,000 | $-65,727,000 | $-46,813,935 | $-17,550,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $7,406,000,000 | $5,587,000,000 | $4,958,000,000 | $5,576,000,000 |
| Total Unusual Items | $-229,000,000 | $-327,000,000 | $-282,000,000 | $-90,000,000 |
| Total Unusual Items Excluding Goodwill | $-229,000,000 | $-327,000,000 | $-282,000,000 | $-90,000,000 |
| Reconciled Depreciation | $729,000,000 | $636,000,000 | $635,000,000 | $608,000,000 |
| EBITDA (Bullshit earnings) | $7,177,000,000 | $5,260,000,000 | $4,676,000,000 | $5,486,000,000 |
| EBIT | $6,448,000,000 | $4,624,000,000 | $4,041,000,000 | $4,878,000,000 |
| Diluted Average Shares | $124,100,000 | $128,100,000 | $134,100,000 | $142,200,000 |
| Basic Average Shares | $123,600,000 | $127,400,000 | $133,200,000 | $141,100,000 |
| Diluted NI Availto Com Stockholders | $4,762,000,000 | $3,295,000,000 | $3,002,000,000 | $3,560,000,000 |
| Minority Interests | $-337,000,000 | $-186,000,000 | $-158,000,000 | $-162,000,000 |
| Tax Provision | $1,102,000,000 | $878,000,000 | $629,000,000 | $905,000,000 |
| Other Special Charges | $-3,000,000 | $108,000,000 | $147,000,000 | $-8,000,000 |
| Restructuring And Mergern Acquisition | $245,000,000 | $286,000,000 | $115,000,000 | $209,000,000 |
| Gain On Sale Of Security | $13,000,000 | $67,000,000 | $-20,000,000 | $111,000,000 |
| Selling General And Administration | $8,096,000,000 | $8,507,000,000 | $8,657,000,000 | $7,776,000,000 |
| Impairment Of Capital Assets | - | - | - | $0 |
| Gain On Sale Of Business | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-17,567,000,000 | $-13,560,000,000 | $-14,213,000,000 | $-14,081,000,000 |
| Total Assets | $82,323,000,000 | $75,140,000,000 | $67,443,000,000 | $62,320,000,000 |
| Total Non Current Assets | $25,113,000,000 | $19,742,000,000 | $19,473,000,000 | $18,028,000,000 |
| Other Non Current Assets | $4,992,000,000 | $3,972,000,000 | $3,186,000,000 | $1,992,000,000 |
| Goodwill And Other Intangible Assets | $15,395,000,000 | $11,486,000,000 | $12,242,000,000 | $12,224,000,000 |
| Other Intangible Assets | $4,079,000,000 | $1,464,000,000 | $2,110,000,000 | $2,277,000,000 |
| Current Assets | $57,210,000,000 | $55,398,000,000 | $47,970,000,000 | $44,292,000,000 |
| Other Current Assets | $1,043,000,000 | $1,063,000,000 | $626,000,000 | $513,000,000 |
| Inventory | $24,207,000,000 | $23,001,000,000 | $21,139,000,000 | $19,691,000,000 |
| Receivables | $27,985,000,000 | $25,643,000,000 | $21,622,000,000 | $19,410,000,000 |
| Receivables Adjustments Allowances | $-259,000,000 | $-500,000,000 | $-921,000,000 | $-158,000,000 |
| Other Receivables | $3,997,000,000 | $3,862,000,000 | $3,104,000,000 | $2,408,000,000 |
| Accounts Receivable | $24,247,000,000 | $22,281,000,000 | $19,439,000,000 | $17,160,000,000 |
| Cash Cash Equivalents And Short Term Investments | $3,975,000,000 | $5,691,000,000 | $4,583,000,000 | $4,678,000,000 |
| Cash And Cash Equivalents | $3,975,000,000 | $5,691,000,000 | $4,583,000,000 | $4,678,000,000 |
| Assets Held For Sale Current | - | - | - | $17,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $2,551,000,000 | - | $1,046,000,000 | $916,000,000 |
| Total Debt | $8,614,000,000 | $7,390,000,000 | $7,390,000,000 | $7,295,000,000 |
| Long Term Debt And Capital Lease Obligation | $7,060,000,000 | $5,941,000,000 | $7,045,000,000 | $6,028,000,000 |
| Long Term Debt | $5,259,000,000 | $4,463,000,000 | $5,579,000,000 | $4,626,000,000 |
| Current Debt And Capital Lease Obligation | $1,554,000,000 | $1,449,000,000 | $345,000,000 | $1,267,000,000 |
| Current Debt | $1,267,000,000 | $1,191,000,000 | $50,000,000 | $968,000,000 |
| Other Current Borrowings | $1,267,000,000 | $1,191,000,000 | $50,000,000 | $968,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $83,157,000,000 | $76,834,000,000 | $69,042,000,000 | $63,810,000,000 |
| Total Non Current Liabilities Net Minority Interest | $16,140,000,000 | $15,230,000,000 | $16,685,000,000 | $15,853,000,000 |
| Other Non Current Liabilities | $7,750,000,000 | $8,260,000,000 | $8,723,000,000 | $8,438,000,000 |
| Non Current Deferred Liabilities | $1,330,000,000 | $1,029,000,000 | $917,000,000 | $1,387,000,000 |
| Non Current Deferred Taxes Liabilities | $1,330,000,000 | $1,029,000,000 | $917,000,000 | $1,387,000,000 |
| Current Liabilities | $67,017,000,000 | $61,604,000,000 | $52,357,000,000 | $47,957,000,000 |
| Payables And Accrued Expenses | $65,463,000,000 | $60,155,000,000 | $52,012,000,000 | $46,690,000,000 |
| Payables | $59,973,000,000 | $55,330,000,000 | $47,097,000,000 | $42,490,000,000 |
| Accounts Payable | $59,973,000,000 | $55,330,000,000 | $47,097,000,000 | $42,490,000,000 |
| Other Current Liabilities | - | - | - | $5,000,000 |
| Equity | ||||
| Common Stock Equity | $-2,172,000,000 | $-2,074,000,000 | $-1,971,000,000 | $-1,857,000,000 |
| Total Equity Gross Minority Interest | $-834,000,000 | $-1,694,000,000 | $-1,599,000,000 | $-1,490,000,000 |
| Stockholders Equity | $-2,172,000,000 | $-2,074,000,000 | $-1,971,000,000 | $-1,857,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-745,000,000 | $-932,000,000 | $-881,000,000 | $-905,000,000 |
| Other Equity Adjustments | $-745,000,000 | $-932,000,000 | $-881,000,000 | $-905,000,000 |
| Retained Earnings | $22,291,000,000 | $17,921,000,000 | $14,978,000,000 | $12,295,000,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $160,000,000 | $154,000,000 | $148,000,000 | $141,000,000 |
| Ordinary Shares Number | $120,000,000 | $125,000,000 | $130,408,286 | $136,000,000 |
| Share Issued | $280,000,000 | $279,000,000 | $278,408,286 | $277,000,000 |
| Tangible Book Value | $-17,567,000,000 | $-13,560,000,000 | $-14,213,000,000 | $-14,081,000,000 |
| Invested Capital | $4,354,000,000 | $3,580,000,000 | $3,658,000,000 | $3,737,000,000 |
| Working Capital | $-9,807,000,000 | $-6,206,000,000 | $-4,387,000,000 | $-3,665,000,000 |
| Capital Lease Obligations | $2,088,000,000 | $1,736,000,000 | $1,761,000,000 | $1,701,000,000 |
| Total Capitalization | $3,087,000,000 | $2,389,000,000 | $3,608,000,000 | $2,769,000,000 |
| Minority Interest | $1,338,000,000 | $380,000,000 | $372,000,000 | $367,000,000 |
| Treasury Stock | $32,005,000,000 | $27,439,000,000 | $24,119,000,000 | $20,997,000,000 |
| Additional Paid In Capital | $8,284,000,000 | $8,373,000,000 | $8,048,000,000 | $7,747,000,000 |
| Capital Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Common Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,801,000,000 | $1,478,000,000 | $1,466,000,000 | $1,402,000,000 |
| Current Capital Lease Obligation | $287,000,000 | $258,000,000 | $295,000,000 | $299,000,000 |
| Current Accrued Expenses | $5,490,000,000 | $4,825,000,000 | $4,915,000,000 | $4,200,000,000 |
| Goodwill | $11,316,000,000 | $10,022,000,000 | $10,132,000,000 | $9,947,000,000 |
| Net PPE | $4,726,000,000 | $4,284,000,000 | $4,045,000,000 | $3,812,000,000 |
| Accumulated Depreciation | $-2,614,000,000 | $-2,529,000,000 | $-2,467,000,000 | $-2,231,000,000 |
| Gross PPE | $7,340,000,000 | $6,813,000,000 | $6,512,000,000 | $6,043,000,000 |
| Construction In Progress | $578,000,000 | $722,000,000 | $441,000,000 | $283,000,000 |
| Other Properties | $2,058,000,000 | $1,782,000,000 | $1,729,000,000 | $1,635,000,000 |
| Machinery Furniture Equipment | $3,151,000,000 | $2,772,000,000 | $2,751,000,000 | $2,603,000,000 |
| Buildings And Improvements | $1,451,000,000 | $1,433,000,000 | $1,482,000,000 | $1,413,000,000 |
| Land And Improvements | $102,000,000 | $104,000,000 | $109,000,000 | $109,000,000 |
| Properties | $0 | $0 | $0 | $0 |
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $5,410,000,000 | $5,226,000,000 | $3,627,000,000 | $4,601,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $6,155,000,000 | $6,085,000,000 | $4,314,000,000 | $5,159,000,000 |
| Cash Flow From Continuing Operating Activities | $6,155,000,000 | $6,085,000,000 | $4,314,000,000 | $5,159,000,000 |
| Operating Gains Losses | $-573,000,000 | $485,000,000 | $-17,000,000 | $-211,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-745,000,000 | $-859,000,000 | $-687,000,000 | $-558,000,000 |
| Investing Cash Flow | $-3,432,000,000 | $-733,000,000 | $-1,072,000,000 | $-542,000,000 |
| Cash Flow From Continuing Investing Activities | $-3,432,000,000 | $-733,000,000 | $-1,072,000,000 | $-542,000,000 |
| Net Other Investing Changes | $-101,000,000 | $-29,000,000 | $-160,000,000 | $-194,000,000 |
| Capital Expenditure Reported | $-309,000,000 | $-322,000,000 | $-256,000,000 | $-168,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-4,750,000,000 | $-3,146,000,000 | $-3,025,000,000 | $-3,638,000,000 |
| Issuance Of Capital Stock | $89,000,000 | $101,000,000 | $116,000,000 | $163,000,000 |
| Financing Cash Flow | $-4,631,000,000 | $-3,965,000,000 | $-3,342,000,000 | $-4,368,000,000 |
| Cash Flow From Continuing Financing Activities | $-4,631,000,000 | $-3,965,000,000 | $-3,342,000,000 | $-4,368,000,000 |
| Net Other Financing Charges | $-372,000,000 | $-554,000,000 | $-175,000,000 | $-324,000,000 |
| Cash Dividends Paid | $-381,000,000 | $-345,000,000 | $-314,000,000 | $-292,000,000 |
| Common Stock Dividend Paid | $-381,000,000 | $-345,000,000 | $-314,000,000 | $-292,000,000 |
| Net Common Stock Issuance | $-4,661,000,000 | $-3,045,000,000 | $-2,909,000,000 | $-3,475,000,000 |
| Common Stock Issuance | $89,000,000 | $101,000,000 | $116,000,000 | $163,000,000 |
| Other | ||||
| Repayment Of Debt | $-10,454,000,000 | $-15,605,000,000 | $-20,899,000,000 | $-9,724,000,000 |
| Issuance Of Debt | $11,237,000,000 | $15,584,000,000 | $20,955,000,000 | $9,447,000,000 |
| Interest Paid Supplemental Data | $212,000,000 | $273,000,000 | $234,000,000 | $224,000,000 |
| Income Tax Paid Supplemental Data | $1,211,000,000 | $1,124,000,000 | $901,000,000 | $562,000,000 |
| End Cash Position | $3,975,000,000 | $5,691,000,000 | $4,583,000,000 | $4,678,000,000 |
| Other Cash Adjustment Outside Changein Cash | $-93,000,000 | $-265,000,000 | $-2,000,000 | $-1,000,000 |
| Beginning Cash Position | $5,956,000,000 | $4,585,000,000 | $4,679,000,000 | $3,935,000,000 |
| Effect Of Exchange Rate Changes | $20,000,000 | $-16,000,000 | $6,000,000 | $25,000,000 |
| Changes In Cash | $-1,908,000,000 | $1,387,000,000 | $-100,000,000 | $719,000,000 |
| Common Stock Payments | $-4,750,000,000 | $-3,146,000,000 | $-3,025,000,000 | $-3,638,000,000 |
| Net Issuance Payments Of Debt | $783,000,000 | - | - | - |
| Net Short Term Debt Issuance | $0 | $0 | $0 | $0 |
| Short Term Debt Payments | $-9,247,000,000 | $-15,086,000,000 | $-19,964,000,000 | $-8,450,000,000 |
| Short Term Debt Issuance | $9,247,000,000 | $15,086,000,000 | $19,964,000,000 | $8,450,000,000 |
| Net Long Term Debt Issuance | $783,000,000 | $-21,000,000 | $56,000,000 | $-277,000,000 |
| Long Term Debt Payments | $-1,207,000,000 | $-519,000,000 | $-935,000,000 | $-1,274,000,000 |
| Long Term Debt Issuance | $1,990,000,000 | $498,000,000 | $991,000,000 | $997,000,000 |
| Net Business Purchase And Sale | $-2,586,000,000 | $155,000,000 | $-225,000,000 | $210,000,000 |
| Sale Of Business | $830,000,000 | $179,000,000 | $47,000,000 | $1,077,000,000 |
| Purchase Of Business | $-3,416,000,000 | $-24,000,000 | $-272,000,000 | $-867,000,000 |
| Net PPE Purchase And Sale | $-436,000,000 | $-537,000,000 | $-431,000,000 | $-390,000,000 |
| Purchase Of PPE | $-436,000,000 | $-537,000,000 | $-431,000,000 | $-390,000,000 |
| Change In Working Capital | $-57,000,000 | $1,155,000,000 | $-64,000,000 | $384,000,000 |
| Change In Other Working Capital | $-339,000,000 | $-136,000,000 | $331,000,000 | $363,000,000 |
| Change In Other Current Liabilities | $-954,000,000 | $-805,000,000 | $-734,000,000 | $-1,426,000,000 |
| Change In Payables And Accrued Expense | $4,317,000,000 | $8,301,000,000 | $4,587,000,000 | $3,788,000,000 |
| Change In Payable | $4,317,000,000 | $8,301,000,000 | $4,587,000,000 | $3,788,000,000 |
| Change In Inventory | $-1,082,000,000 | $-2,270,000,000 | $-1,294,000,000 | $-1,259,000,000 |
| Change In Receivables | $-1,999,000,000 | $-3,935,000,000 | $-2,954,000,000 | $-1,082,000,000 |
| Other Non Cash Items | $572,000,000 | $470,000,000 | $341,000,000 | $559,000,000 |
| Provisionand Write Offof Assets | $100,000,000 | $-130,000,000 | $819,000,000 | $45,000,000 |
| Asset Impairment Charge | $55,000,000 | $98,000,000 | $43,000,000 | $72,000,000 |
| Deferred Tax | $230,000,000 | $-110,000,000 | $-603,000,000 | $-20,000,000 |
| Deferred Income Tax | $230,000,000 | $-110,000,000 | $-603,000,000 | $-20,000,000 |
| Depreciation Amortization Depletion | $729,000,000 | $636,000,000 | $635,000,000 | $608,000,000 |
| Depreciation And Amortization | $729,000,000 | $636,000,000 | $635,000,000 | $608,000,000 |
| Amortization Cash Flow | $473,000,000 | $394,000,000 | $382,000,000 | $360,000,000 |
| Amortization Of Intangibles | $473,000,000 | $394,000,000 | $382,000,000 | $360,000,000 |
| Depreciation | $256,000,000 | $242,000,000 | $253,000,000 | $248,000,000 |
| Gain Loss On Sale Of Business | $-573,000,000 | $485,000,000 | $-17,000,000 | $-211,000,000 |
| Net Income From Continuing Operations | $5,099,000,000 | $3,481,000,000 | $3,160,000,000 | $3,722,000,000 |
| Other Cash Adjustment Inside Changein Cash | - | $0 | $0 | $470,000,000 |
| Earnings Losses From Equity Investments | - | - | - | - |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |